Hoydonckx, Yasmine https://orcid.org/0000-0003-0893-8813
Singh, Mandeep
Gilron, Ian
Khan, James
Narouze, Samer
Dahan, Albert
Curtis, Kathryn
Cao, Xingshan
Kara, Jamal
Bhatia, Anuj
Funding for this research was provided by:
Canadian Pain Society
Pfizer Canada
Article History
Received: 8 November 2022
Accepted: 18 February 2023
First Online: 1 March 2023
Declarations
:
: This trial protocol has been approved by the Clinical Research Ethics Review Board of UHN (#21-5523) on December 24, 2021, and Sinai Healthy System (# 22-0044-A) on October 28, 2022, and Health Canada authorization (#263255) was obtained on February 9, 2022. Informed consent to participate will be obtained from all participants (Additional file : Appendix 2).
: N/A
: Dr. Yasmine Hoydonckx received the Canadian Pain Society (CPS)/Pfizer Early Career Investigator Pain Research Grant. The other authors declare that they have no competing interests.